VIVUS (STU:VIU1) Dividend Payout Ratio : 0.00 (As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS Dividend Payout Ratio?

VIVUS's dividend payout ratio for the months ended in Mar. 2020 was 0.00.

The historical rank and industry rank for VIVUS's Dividend Payout Ratio or its related term are showing as below:

STU:VIU1's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.455
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-15), the Dividend Yield % of VIVUS is 0.00%.

VIVUS's Dividends per Share for the months ended in Mar. 2020 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

VIVUS Dividend Payout Ratio Historical Data

The historical data trend for VIVUS's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Dividend Payout Ratio Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dividend Payout Ratio

Get a 7-Day Free Trial

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of VIVUS's Dividend Payout Ratio

For the Biotechnology subindustry, VIVUS's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIVUS's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where VIVUS's Dividend Payout Ratio falls into.

VIVUS Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

VIVUS's Dividend Payout Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2019 )	/	EPS without NRI (A: Dec. 2019 )
	=	0	/	-2.664
	=	N/A

VIVUS's Dividend Payout Ratio for the quarter that ended in Mar. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2020 )	/	EPS without NRI (Q: Mar. 2020 )
	=	0	/	-0.443
	=	N/A

VIVUS (STU:VIU1) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

VIVUS Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of VIVUS's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines